Fortress Biotech, Inc
Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; and Ala-Quin, an antibacterial and antifungal cream. The company also develops MB-107, a gene therapy for X-linked severe combined immunodeficiency; CAEL-101, a Phase Ia/Ib trial that reduces amyloid deposits in the tissues and organs; CD123 chimeric antigen receptor engineered T-cell (CAR T) program for acute myeloid leukemia; CD20 CAR T program for B cell non-Hodgkin lymphoma; and CS1 CAR T for multiple myeloma and light chain amyloidosis. In addition, it develops MB-101 for Glioblastoma (GBM); MB-103 for GBM, and breast cancer and brain metastases; MB-105 for prostate and pancreatic cancers; intravenous Tramadol for post-operative pain; CK-101, a Phase I/II clinical trial for treating patients with EGFR mutation-positive non-small cell lung cancer; CK-301, a Phase I clinical trial for metastatic cancer; Triplex, a Phase I study recombinant modified vaccinia ankara viral vector vaccine; ConVax, a recombinant modified vaccinia ankara viral vector vaccine; CEVA-101 for traumatic brain injury; CEVA-D, a bioreactor device that enhances the anti-inflammatory potency of bone marrow-derived cells; Tamid-001, a gene therapy for mucopolysaccharidosis type I disorder; CNDO-109, a lysate that activates donor natural killer cells; and methazalomide products. The company has collaboration arrangements with some universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was founded in 2006 and is based in New York, New York. Show More...
-
Website http://www.fortressbiotech.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 16.20 USD
-
Last Updated 06-05-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD Dividends USD Payout Ratio % * Shares Mil Book Value Per Share * USD Free Cash Flow Per Share * USD Return on Assets % -180.62 -85.79 -52.49 -21.47 -46.58 -38.08 -32.1 -43.49 -21.75 -25.03 Financial Leverage (Average) 1.22 1.86 1.24 1.27 2.09 4.44 4.68 76.17 8.64 6.15 Return on Equity % -220.68 -134.14 -71.93 -26.86 -76.04 -115.57 -146.87 -309.23 -284.77 -185.11 Return on Invested Capital % -212.66 -93.25 -54.44 -21.92 -57.12 -70.36 -68.73 -74.75 -27.54 -31.03 Interest Coverage -30.89 -473.57 -40.58 -18.52 -14.24 -35.31 -18.32 -15.78 -11.65 -7.58 -7.75 Current Ratio 6.69 7.91 8.92 17.28 9.43 1.94 2.72 2.0 3.43 3.07 Quick Ratio 6.63 7.83 8.88 17.11 9.28 1.77 2.53 1.63 3.31 2.97 Debt/Equity 0.04 0.58 0.09 0.2 0.41 0.68 1.01 32.64 4.05 2.68